PBF-1129 in Patients With NSCLC

Clinical trial NCT03274479 · UNKNOWN

Trial details

NCT number: NCT03274479
Sponsor: Palobiofarma SL
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic NSCLC

Start date: 2018-10-01
Primary completion: 2024-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.